Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma

Pancreas

Volumn 18, Issue 2, 1999, Pages 111-116

  Adsay, N Volkan ^a   Dergham, Sanaa T ^a   Koppitch, Frederick C ^a   Dugan, Michael C ^a   Mohamed, Anwar N ^a   Vaitkevicius, Vainutis K ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C myc; Chromosome; FISH; Fluorescence in situ hybridization; Molecular alteration; Pancreatic cancer

Indexed keywords

ARTICLE; CANCER STAGING; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 20; CHROMOSOME 7; CHROMOSOME 8; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; ONCOGENE C MYC; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL;

EID: 0344177624     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199903000-00001     Document Type: Article

References (28)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA: Cancer J Clin 1998;48(1):6-29.
2. Evans DB, Abruzzese JL, Rich AT. Cancer of the pancreas. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Vol 5. New York: Lippincott-Raven, 1997: 1054-87.
3. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, Bentz M, Gress T, Lichter P. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996; 56(16):3803-7.
4. Kimura M, Abe T, Sunamura M, Matsuno S, Horii A. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: identification of a 1-cm region of common allelic loss. Genes Chromosomes Cancer 1996;17(2):88-93.
5. Fukushige S, Waldman FM, Kimura M, et al. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 1997;19(3): 161-9.
6. Mahlamaki EH, Hoglund M, Gorunova L, et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 2p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 1997;20(4):383-91.
7. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271 (5247):350-3.
8. Achille A, Biasi MO, Zamboni G, et al. Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 1996;56(16):3808-13.
9. Gorunova L, Johansson B, Dawiskiba S, et al. Massive cytogenetic heterogeneity in a pancreatic carcinoma: fifty-four karyotypically unrelated clones. Genes Chromosomes Cancer 1995;14(4):259-66.
10. Caldas C, Hahn SA, da Costa LT, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma [published erratum appears in Nature Genet 1994; 8(4):410]. Nature Genet 1994;8(1):27-32.
11. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F, Yeo CJ. Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 1994;9(2):93-100.
12. Ruggeri B, Zhang SY, Klein-Szanto AJ. Molecular and cytogenetic alterations in human pancreatic cancer: the role of tumor suppressor genes. Prog Clin Biol Res 1992;376:245-60.
13. Michelassi F, Erroi F, Angriman I, Westbrook C. Chromosome 5 allele loss in human gastric, ampullary and pancreatic carcinomas. Ital J Surg Sci 1989;19(4):341-4.
14. Johansson B, Mandahl N, Heim S, Mertens F, Andren-Sandberg A, Mitelam F. Chromosome abnormalities in a pancreatic adenocarcinoma. Cancer Genet Cytogenet 1989;37(2):209-13.
15. Pandya A, Blanton SH, Landa B, et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cm region on 7q. Genomics 1996;38(2):227-30.
16. Korc M, Meltzer P, Trent J. Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Nat Acad Sci USA 1986;83(14): 5141-4.
17. Brat DJ, Hahn SA, Griffin CA, Yeo CJ, Kern SE, Hruban RH. The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. Am J Pathol 1997;150(2):383-91.
18. Neuman WL, Wasylyshyn ML, Jacoby R, et al. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromosomes Cancer 1991;3(6):468-73.
19. Griffin CA, Hruban RH, Morsberger LA, et al. Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 1995;55(11):2394-9.
20. Hohne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res 1992;52(9):2616-9.
21. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996;56(11):2527-30.
22. Johansson B, Bardi G, Pandis N, et al. Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade. Int J Cancer 1994;58(1):8-13.
23. Han HJ, Yanagisawa A, Kato Y, Park JG, Nakamura Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993;53(21):5087-9.
24. Micale MA, Sanford JS, Powell IJ, Sakr WA, Wolman SR. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 1993;69(1):7-12.
25. Seymour AB, Hruban RH, Redston M, et al. Allelotype of pancreatic adenocarcinoma. Cancer Res 1994;54(10):2761-4.
26. Simon B, Weinel R, Hohne M, et al. Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. Gastroenterology 1994;106(6):1645-51.
27. Miwa W, Yashima K, Sekine T, Sekiya T. Demethylation of a repetitive DNA sequence in human cancers. Electrophoresis 1995; 16(2):227-32.
28. Wasylyshyn ML, Neuman WL, Angriman I, et al. Evidence for a new tumor-suppressor gene involved in gastrointestinal malignancies. Surgery 1991;110(2):265-8; discussion 268-9.